law://eu/reg/2023/256@2026-11-17THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutritionnote, and in particular Article 9(2) thereof,Whereas:
HAS ADOPTED THIS REGULATION:
| Identification number of the additive | Name of the holder of authorisation | Additive | Composition, chemical formula, description, analytical method | Species or category of animal | Maximum age | Minimum content | Maximum content | Other provisions | End of period of authorisation |
|---|---|---|---|---|---|---|---|---|---|
| CFU/kg of complete feedingstuff with a moisture content of 12 % | |||||||||
| Category: zootechnical additives. Functional group: gut flora stabilisers. | |||||||||
| 4b1850 | NBF Lanes s.r.l. | Limosilactobacillus reuteriDSM 32203 | Additive compositionPreparation of Limosilactobacillus reuteriDSM 32203 containing a minimum of 1 × 1011 CFU/gSolid form | Dogs | - | 1 × 1010 | - | 1. Post-market monitoring is required on the effects of the additive on constipation for a long-term use.2. In the directions for use of the additive and premixtures, the storage conditions and stability to heat treatment shall be indicated.3. On the label of the additive and premixtures, the following shall be indicated: The decision to supplement dogs with Limosilactobacillus reuteri DSM 32203 for a period longer than five weeks should take into account the characteristics of the supplemented feed and diet, the breed of dog and the availability of water, in order to avoid constipation.4. For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address potential risks resulting from their use. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixtures shall be used with personal protective equipment, including eyes, skin and breathing protection. |
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.
| 27 February 2033 |
| Characterisation of the active substance:Viable cells of Limosilactobacillus reuteriDSM 32203 |
| Analytical methodnoteIdentification: DNA sequencing methods or pulsed Field Gel Electrophoresis (PFGE)Enumeration in feed additive and compound feed: spread plate method on MRS agar (EN 15787) |
| Identification number of the additive | Name of the holder of authorisation | Additive | Composition, chemical formula, description, analytical method | Species or category of animal | Maximum age | Minimum content | Maximum content | Other provisions | End of period of authorisation |
|---|---|---|---|---|---|---|---|---|---|
| CFU/kg of complete feedingstuff with a moisture content of 12 % | |||||||||
| Category: zootechnical additives. Functional group: gut flora stabilisers. | |||||||||
| 4b1851 | NBF Lanes s.r.l. | Limosilactobacillus reuteri DSM 32264 | Additive compositionPreparation of Limosilactobacillus reuteri DSM 32264 containing a minimum of 1 × 1011 CFU/gSolid form | Cats | - | 1 × 1010 | - | 1. Post-market monitoring is required on the effects of the additive on constipation for a long-term use.2. In the directions for use of the additive and premixtures, the storage conditions and stability to heat treatment shall be indicated.3. On the label of the additive and premixtures, the following shall be indicated: The decision to supplement cats with Limosilactobacillus reuteri DSM 32264 for a period longer than five weeks should take into account the characteristics of the supplemented feed and diet, the breed of cat and the availability of water, in order to avoid constipation.4. For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address potential risks resulting from their use. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixtures shall be used with personal protective equipment, including eyes, skin and breathing protection. | 27 February 2033 |
| Characterisation of the active substance:Viable cells of Limosilactobacillus reuteri DSM 32264 | |||||||||
| Analytical methodnoteIdentification: DNA sequencing methods or pulsed Field Gel Electrophoresis (PFGE)Enumeration in feed additive and compound feed: spread plate method on MRS agar (EN 15787) |